Misonix
Company

Last deal

$30M

Amount

Post-IPO Secondary

Stage

23.01.2020

Date

2

all rounds

$55M

Total amount

General

About Company
Misonix is a world leader in the design, development, manufacturing, and marketing of ultrasonic surgical devices.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1955

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Secondary

IPO status

Private

Description

Misonix specializes in the development and commercialization of ultrasonic surgical devices for various medical procedures. Their innovative products, such as BoneScalpel and SonaStar, are used in neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgery. With a global presence in over 45 countries, Misonix offers advanced surgical tools that provide unprecedented safety, speed, and precision. Their portfolio of products is based on the unique properties of ultrasound, enabling differentiation between hard and soft tissue for different clinical requirements. By enhancing clinical outcomes, Misonix aims to transform patients' lives with better products that make a difference. You can find more information on their website at www.misonix.com.